Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in J Nephrol Retrieve available abstracts of 100 articles: HTML format

Single Articles

April 2024
1. SHAHEEN M, Bharat A, Friedman AN, Guo S, et al
   ALECT2 amyloidosis with concurrent IgG4-related interstitial nephritis, membranous nephropathy and diabetic kidney disease: a case report and literature review.
   J Nephrol. 2024 Apr 17. doi: 10.1007/s40620-024-01924.
   PubMed     Abstract available
   
   
   March 2024
2. ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
   Class V lupus nephritis recurrence with histologic resolution in a kidney transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson for the clinical nephrologist.
   J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
   PubMed    
   
   
   
3. HU D, Wang Z, Wang S, Li Y, et al
   Lymphatic vessels in patients with crescentic glomerulonephritis: association with renal pathology and prognosis.
   J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
   PubMed     Abstract available
   
   
   
4. REN W, Sun J, Zhang L, He W, et al
   Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy.
   J Nephrol. 2024 Mar 21. doi: 10.1007/s40620-024-01893.
   PubMed     Abstract available
   
   
   
5. ARNAERT S, Schepens N, Deleu L, Malfait T, et al
   Case report: renal recovery in Goodpasture's syndrome treated with rituximab.
   J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-024-01892.
   PubMed     Abstract available
   
   
   
6. VAZ DE CASTRO PAS, Amaral AA, Almeida MG, Selvaskandan H, et al
   Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.
   J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874.
   PubMed     Abstract available
   
   
   February 2024
7. CHRISTODOULOU M, Moysidou E, Lioulios G, Stai S, et al
   The prognostic value of two histopathologic classification models of ANCA-associated glomerulonephritis: a prospective study.
   J Nephrol. 2024 Feb 12. doi: 10.1007/s40620-023-01855.
   PubMed     Abstract available
   
   
   
8. OCHIAI S, Kikuchi M, Kaikita K, Fujimoto S, et al
   Rapidly progressive glomerulonephritis due to IgA nephropathy accompanied by collagenofibrotic glomerulopathy. A nephrology picture.
   J Nephrol. 2024 Feb 6. doi: 10.1007/s40620-023-01875.
   PubMed    
   
   
   January 2024
9. TRIMARCHI H, Fervenza FC, Coppo R
   Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
   J Nephrol. 2024 Jan 18. doi: 10.1007/s40620-023-01833.
   PubMed     Abstract available
   
   
   
10. HE WJ, Wang J, Liu N, Li GY, et al
    The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    J Nephrol. 2024 Jan 16. doi: 10.1007/s40620-023-01839.
    PubMed     Abstract available
    
    
    December 2023
11. SCHENA FP, Cox SN
    Correction to: Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Dec 8. doi: 10.1007/s40620-023-01861.
    PubMed    
    
    
    
12. BOUSSETTA A, Jellouli M, Hajji M, Rekaya S, et al
    A membranous nephropathy in a 5 year-old boy: and if that's not all? A nephrology quiz.
    J Nephrol. 2023 Dec 6. doi: 10.1007/s40620-023-01821.
    PubMed    
    
    
    November 2023
13. ALBERTAZZI V, Fontana F, Giberti S, Aiello V, et al
    Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
    J Nephrol. 2023 Nov 13. doi: 10.1007/s40620-023-01803.
    PubMed     Abstract available
    
    
    
14. BANJONGJIT A, Thammathiwat T, Townamchai N, Kanjanabuch T, et al
    SARS-CoV-2 infection associated with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN): a systematic review and two case reports.
    J Nephrol. 2023 Nov 6. doi: 10.1007/s40620-023-01777.
    PubMed     Abstract available
    
    
    
15. RUSSWURM M, Kortus-Goetze B, Maier-Giebing T, Groene HJ, et al
    General prognostic models may neglect vulnerable subgroups in ANCA-associated vasculitis.
    J Nephrol. 2023;36:2269-2280.
    PubMed     Abstract available
    
    
    
16. GOTO K, Imaizumi T, Hamada R, Ishikura K, et al
    Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017.
    J Nephrol. 2023;36:2257-2267.
    PubMed     Abstract available
    
    
    
17. XIONG L, Liu L, Tao Y, Guo H, et al
    Clinical significance of IgM and C3 deposition in children with primary immunoglobulin A nephropathy.
    J Nephrol. 2023;36:2213-2222.
    PubMed     Abstract available
    
    
    
18. RAO IR, Kolakemar A, Shenoy SV, Prabhu RA, et al
    Hydroxychloroquine in nephrology: current status and future directions.
    J Nephrol. 2023;36:2191-2208.
    PubMed     Abstract available
    
    
    
19. SCURT FG, Hirschfeld V, Ganz M, Mertens PR, et al
    Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    J Nephrol. 2023;36:2281-2293.
    PubMed     Abstract available
    
    
    
20. WANG F, Jin Y, Zhou F, Luo L, et al
    Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    J Nephrol. 2023;36:2295-2304.
    PubMed     Abstract available
    
    
    
21. ROCCATELLO D, Careddu A, Ferro M, Naretto C, et al
    The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy.
    J Nephrol. 2023;36:2223-2231.
    PubMed     Abstract available
    
    
    
22. ALVAREZ L, Kambham N, Su R
    Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.
    J Nephrol. 2023;36:2365-2370.
    PubMed     Abstract available
    
    
    October 2023
23. LIU Z, Wan C, Cao Y, Liu S, et al
    Distribution spectrum and clinical significance of glomerular exostosin (EXT1) deposits in PLA2R-positive membranous nephropathy.
    J Nephrol. 2023 Oct 26. doi: 10.1007/s40620-023-01779.
    PubMed     Abstract available
    
    
    
24. PALA C, Parenti E, Vizzini G, Gianfreda D, et al
    Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab.
    J Nephrol. 2023 Oct 17. doi: 10.1007/s40620-023-01789.
    PubMed     Abstract available
    
    
    
25. MONGERA N, Passler W, Sethi S, Kozakowski N, et al
    A case of protocadherin FAT1-positive membranous nephropathy secondary to hematopoietic stem-cell transplantation.
    J Nephrol. 2023 Oct 10. doi: 10.1007/s40620-023-01786.
    PubMed    
    
    
    September 2023
26. PAOLO SF, Natasha CS
    Is it time for personalized therapy in IgA nephropathy patients?
    J Nephrol. 2023 Sep 22. doi: 10.1007/s40620-023-01745.
    PubMed    
    
    
    
27. AI S, Yan X, Zhao X, Ye W, et al
    Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
    J Nephrol. 2023 Sep 15. doi: 10.1007/s40620-023-01751.
    PubMed     Abstract available
    
    
    
28. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
    Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
    J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
    PubMed     Abstract available
    
    
    
29. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
    Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
    J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
    PubMed    
    
    
    August 2023
30. TERINTE-BALCAN G, Stancu S, Zugravu A, Capusa C, et al
    Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    J Nephrol. 2023 Aug 26. doi: 10.1007/s40620-023-01744.
    PubMed     Abstract available
    
    
    
31. CEOL M, Gianesello L, Trimarchi H, Migliorini A, et al
    Human parietal epithelial cells (PECs) and proteinuria in lupus nephritis: a role for ClC-5, megalin, and cubilin?
    J Nephrol. 2023 Aug 18. doi: 10.1007/s40620-023-01725.
    PubMed     Abstract available
    
    
    July 2023
32. LU H, Li Y, Lai M, Guan T, et al
    Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study.
    J Nephrol. 2023 Jul 31. doi: 10.1007/s40620-023-01685.
    PubMed     Abstract available
    
    
    
33. VASURI F, Lisi AP, Ciavarella C, Degiovanni A, et al
    Caveolin-1 in situ expression in glomerular and peritubular capillaries as a marker of ultrastructural progression and severity of renal thrombotic microangiopathy.
    J Nephrol. 2023 Jul 22. doi: 10.1007/s40620-023-01645.
    PubMed     Abstract available
    
    
    
34. KOBAYASHI H, Satake E, Murata Y, Otsuka H, et al
    Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
    J Nephrol. 2023 Jul 12. doi: 10.1007/s40620-023-01704.
    PubMed     Abstract available
    
    
    June 2023
35. WATANABE H, Yamana H, Okada A, Matsui H, et al
    Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.
    J Nephrol. 2023 Jun 24. doi: 10.1007/s40620-023-01695.
    PubMed     Abstract available
    
    
    
36. JANKOWSKI E, Schlosser M, Wiech T, Wolf G, et al
    SARS-CoV-2 infection: a possible trigger for the recurrence of IgA nephropathy after kidney transplantation?
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01684.
    PubMed     Abstract available
    
    
    
37. FAN Y, Kang D, Chen Z, Lu Y, et al
    Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies.
    J Nephrol. 2023 Jun 21. doi: 10.1007/s40620-023-01622.
    PubMed     Abstract available
    
    
    
38. ZAPPI S, Bernasconi L, Fischer I, Hoxha E, et al
    Lesson for the clinical nephrologist: thrombospondin type-1 domain-containing protein 7A-associated membranous nephropathy and Fanconi syndrome in a patient with a squamous cell lung cancer.
    J Nephrol. 2023 Jun 9. doi: 10.1007/s40620-023-01630.
    PubMed    
    
    
    
39. ZHANG L, Du M, Tu Y, Liang D, et al
    Clinicopathological features and long-term prognosis of glomerular diseases associated with mercury-containing cosmetics.
    J Nephrol. 2023;36:1401-1407.
    PubMed     Abstract available
    
    
    May 2023
40. WEHRMANN F, von Bergwelt-Baildon A, Schonermarck U
    Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle.
    J Nephrol. 2023 May 31. doi: 10.1007/s40620-023-01659.
    PubMed    
    
    
    
41. AGRAWAL A, Chong GY, Fidler ME, Cramer Ii CH, et al
    Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression.
    J Nephrol. 2023;36:1169-1174.
    PubMed     Abstract available
    
    
    April 2023
42. SOMA Y, Kato M, Shimura G, Kamio M, et al
    Renal biopsy diagnosis of IgG4-related kidney disease with minor hematuria and mild renal dysfunction: lessons for the clinical nephrologist.
    J Nephrol. 2023;36:639-642.
    PubMed    
    
    
    
43. ZHU M, Wang J, Le W, Xu F, et al
    Relationship between anti-GBM antibodies and kidney outcomes in patients with anti-GBM disease.
    J Nephrol. 2023;36:789-797.
    PubMed     Abstract available
    
    
    March 2023
44. LACETERA R, Calatroni M, Roggero L, Radice A, et al
    Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review.
    J Nephrol. 2023 Mar 20. doi: 10.1007/s40620-023-01574.
    PubMed     Abstract available
    
    
    
45. LI JP, Du YT, Guo C, Rao XR, et al
    IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAkappa deposits: a pattern switch.
    J Nephrol. 2023 Mar 13. doi: 10.1007/s40620-023-01583.
    PubMed     Abstract available
    
    
    
46. HE G, Tao L, Li C, Zhong X, et al
    The spectrum and changes of biopsy-proven kidney diseases in Chinese children.
    J Nephrol. 2023;36:417-427.
    PubMed     Abstract available
    
    
    February 2023
47. RONSIN C, Jacquemont L, Testa A, Renaudin K, et al
    ANCA-negative pauci-immune crescentic glomerulonephritis associated with Fabry disease: lesson for the clinical nephrologist.
    J Nephrol. 2023 Feb 16. doi: 10.1007/s40620-022-01533.
    PubMed    
    
    
    
48. FONTANA F, Delsante M, Vicari M, Pala C, et al
    Mycophenolate mofetil plus steroids compared to steroids alone in IgA nephropathy: a retrospective study.
    J Nephrol. 2023 Feb 15. doi: 10.1007/s40620-023-01578.
    PubMed    
    
    
    
49. SU X, Song R, Li S, Guo W, et al
    Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
    J Nephrol. 2023 Feb 14. doi: 10.1007/s40620-022-01550.
    PubMed     Abstract available
    
    
    January 2023
50. VILLEGAS-GAMAS JM, Marquez-Macedo SE, Jimenez-Franco B, Fonseca-Correa JI, et al
    Proliferative glomerulonephritis with monoclonal IgG deposits triggered by Filgrastim in a patient with multiple myeloma.
    J Nephrol. 2023 Jan 18. doi: 10.1007/s40620-022-01555.
    PubMed    
    
    
    
51. LIE DNW, Chan KW, Tang AHN, Chan ATP, et al
    Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study.
    J Nephrol. 2023 Jan 11. doi: 10.1007/s40620-022-01530.
    PubMed     Abstract available
    
    
    
52. TANAKA M, Moniwa N, Nogi C, Kano T, et al
    Glomerular expression and urinary excretion of fatty acid-binding protein 4 in IgA nephropathy.
    J Nephrol. 2023 Jan 9. doi: 10.1007/s40620-022-01551.
    PubMed     Abstract available
    
    
    December 2022
53. HE L, Wang H, He P, Jiang Y, et al
    Serum Long Noncoding RNA H19 and CKD Progression in IgA Nephropathy.
    J Nephrol. 2022 Dec 27. doi: 10.1007/s40620-022-01536.
    PubMed     Abstract available
    
    
    
54. BAIER E, Kluge IA, Hakroush S, Tampe D, et al
    Leukocyturia and hematuria enable non-invasive differentiation of Bowman's capsule rupture severity in PR3-ANCA glomerulonephritis.
    J Nephrol. 2022 Dec 21. doi: 10.1007/s40620-022-01486.
    PubMed     Abstract available
    
    
    
55. HUANG Z, Hu Y, Chen B, Liang Y, et al
    Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
    J Nephrol. 2022 Dec 20. doi: 10.1007/s40620-022-01511.
    PubMed     Abstract available
    
    
    
56. KADEMANI SP, Nelaturi P, Sathyasagar K, Ravikumar S, et al
    Noncoding RNAs associated with IgA nephropathy.
    J Nephrol. 2022 Dec 10. doi: 10.1007/s40620-022-01498.
    PubMed     Abstract available
    
    
    
57. ALLINOVI M, Lugli G, Rossi F, Palterer B, et al
    Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy: a single-center experience and a systematic review of the literature.
    J Nephrol. 2022 Dec 3. doi: 10.1007/s40620-022-01528.
    PubMed    
    
    
    
58. POPA O, Capusa C, Stefan G, Mandache E, et al
    How useful is kidney biopsy for the management of glomerulopathies in the elderly?
    J Nephrol. 2022;35:2301-2312.
    PubMed     Abstract available
    
    
    
59. MOGUEL GONZALEZ B, Garcia Nava M, Orozco Guillen OA, Soto Abraham V, et al
    Kidney biopsy during pregnancy: a difficult decision. A case series reporting on 20 patients from Mexico.
    J Nephrol. 2022;35:2293-2300.
    PubMed     Abstract available
    
    
    November 2022
60. STAI S, Lioulios G, Christodoulou M, Papagianni A, et al
    From KDIGO 2012 towards KDIGO 2021 in idiopathic membranous nephropathy guidelines: what has changed over the last 10 years?
    J Nephrol. 2022 Nov 30. doi: 10.1007/s40620-022-01493.
    PubMed     Abstract available
    
    
    
61. GREVE AS, Prakash S, Krag S, Randers E, et al
    Focal segmental glomerulosclerosis in a patient with multiple sclerosis treated with Teriflunomide and Ocrelizumab.
    J Nephrol. 2022 Nov 21. doi: 10.1007/s40620-022-01504.
    PubMed     Abstract available
    
    
    October 2022
62. SCHENA FP, Anelli VW, Di Noia T, Tripepi G, et al
    Post-hoc analysis of a tool to predict kidney failure in patients with IgA nephropathy.
    J Nephrol. 2022 Oct 21. pii: 10.1007/s40620-022-01463.
    PubMed     Abstract available
    
    
    
63. CLAUDIO P
    Primary membranous nephropathy: an endless story.
    J Nephrol. 2022 Oct 17. pii: 10.1007/s40620-022-01461.
    PubMed     Abstract available
    
    
    
64. DE SOUZA L, Ismail I, Baade R, Mantha M, et al
    Lessons for the clinical nephrologist: dialysis decisions in early pregnancy for acute kidney injury due to post-infectious glomerulonephritis (PIGN).
    J Nephrol. 2022 Oct 14. pii: 10.1007/s40620-022-01464.
    PubMed    
    
    
    
65. CHBIHI M, Eveillard LA, Riller Q, Brousse R, et al
    Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
    J Nephrol. 2022 Oct 8. pii: 10.1007/s40620-022-01438.
    PubMed     Abstract available
    
    
    September 2022
66. SEIKRIT C, Schimpf JI, Wied S, Stamellou E, et al
    Intestinal permeability in patients with IgA nephropathy and other glomerular diseases: an observational study.
    J Nephrol. 2022 Sep 15. pii: 10.1007/s40620-022-01454.
    PubMed     Abstract available
    
    
    
67. XU L, Kant S, Aqeel F, Antiochos B, et al
    Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    J Nephrol. 2022 Sep 9. pii: 10.1007/s40620-022-01460.
    PubMed    
    
    
    August 2022
68. TAMPE D, Baier E, Hakroush S, Tampe B, et al
    Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    J Nephrol. 2022 Aug 13. pii: 10.1007/s40620-022-01414.
    PubMed     Abstract available
    
    
    
69. STEFAN G, Zugravu A, Stancu S
    Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy.
    J Nephrol. 2022 Aug 12. pii: 10.1007/s40620-022-01426.
    PubMed    
    
    
    July 2022
70. WU Q, Liang D, Song T, Ni X, et al
    Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study.
    J Nephrol. 2022 Jul 22. pii: 10.1007/s40620-022-01385.
    PubMed     Abstract available
    
    
    
71. XIE M, Zhu Y, Wang X, Ren J, et al
    Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.
    J Nephrol. 2022 Jul 4. pii: 10.1007/s40620-022-01363.
    PubMed     Abstract available
    
    
    May 2022
72. PICCOLI GB
    The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis?
    J Nephrol. 2022 May 11. pii: 10.1007/s40620-022-01343.
    PubMed    
    
    
    
73. OKI R, Unagami K, Taneda S, Takagi T, et al
    Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    J Nephrol. 2022 May 6. pii: 10.1007/s40620-022-01332.
    PubMed     Abstract available
    
    
    
74. TAMPE D, Hakroush S, Biggemann L, Winkler MS, et al
    Kinetics of human leukocyte antigen receptor HLA-DR(+) monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis.
    J Nephrol. 2022;35:1283-1287.
    PubMed     Abstract available
    
    
    
75. TESAR V, Hruskova Z
    Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients.
    J Nephrol. 2022;35:1065-1068.
    PubMed    
    
    
    
76. MAKATI D, Akers J, Aljuhani M, Pellegrino B, et al
    Prevalence of ANCA-associated vasculitis amid natural gas drilling sites in West Virginia.
    J Nephrol. 2022;35:1185-1192.
    PubMed     Abstract available
    
    
    April 2022
77. LIU M, Yu X, Wang S, Qin A, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes.
    J Nephrol. 2022 Apr 23. pii: 10.1007/s40620-022-01317.
    PubMed     Abstract available
    
    
    
78. DUAN T, Zhu X, Zhao Q, Xiao L, et al
    Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.
    J Nephrol. 2022 Apr 18. pii: 10.1007/s40620-022-01316.
    PubMed     Abstract available
    
    
    
79. HAKROUSH S, Kluge IA, Baier E, Korsten P, et al
    pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis.
    J Nephrol. 2022 Apr 5. pii: 10.1007/s40620-022-01320.
    PubMed    
    
    
    March 2022
80. RUAN Y, Hong F, Wu J, Lin M, et al
    Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents.
    J Nephrol. 2022 Mar 15. pii: 10.1007/s40620-022-01273.
    PubMed     Abstract available
    
    
    
81. DEL VECCHIO L, Locatelli F, Ponticelli C
    The treatment of membranous nephropathy: a journey in the search for evidence.
    J Nephrol. 2022 Mar 1. pii: 10.1007/s40620-022-01291.
    PubMed    
    
    
    
82. REZAC J, Honsova E, Masek M, Rysava R, et al
    Granulomatosis with polyangiitis mimicking cancer: a diagnostic dilemma.
    J Nephrol. 2022;35:675-678.
    PubMed    
    
    
    February 2022
83. FAUCON AL, Cereja S, Mussini C, Goujon JM, et al
    Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.
    J Nephrol. 2022 Feb 24. pii: 10.1007/s40620-022-01278.
    PubMed    
    
    
    
84. BOSE B, Chung EYM, Hong R, Strippoli GFM, et al
    Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.
    J Nephrol. 2022 Feb 23. pii: 10.1007/s40620-022-01268.
    PubMed     Abstract available
    
    
    December 2021
85. HAKROUSH S, Tampe B
    Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
    J Nephrol. 2021 Dec 1. pii: 10.1007/s40620-021-01208.
    PubMed     Abstract available
    
    
    
86. WANG K, Yu Z, Huang Y, Yang K, et al
    Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.
    J Nephrol. 2021;34:1887-1896.
    PubMed     Abstract available
    
    
    November 2021
87. CHENG YJ, Cheng XY, Zhang YM, Wang F, et al
    Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
    J Nephrol. 2021 Nov 30. pii: 10.1007/s40620-021-01182.
    PubMed     Abstract available
    
    
    
88. CALISKAN Y, Demir E, Karatay E, Ozluk Y, et al
    Oxidative stress and macrophage infiltration in IgA nephropathy.
    J Nephrol. 2021 Nov 16. pii: 10.1007/s40620-021-01196.
    PubMed     Abstract available
    
    
    
89. MANENTI L, Rossi GM, Pisani I, Gentile M, et al
    IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.
    J Nephrol. 2021 Nov 10. pii: 10.1007/s40620-021-01189.
    PubMed     Abstract available
    
    
    
90. HAKROUSH S, Gersmann AK, Tampe B
    Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis.
    J Nephrol. 2021 Nov 6. pii: 10.1007/s40620-021-01169.
    PubMed    
    
    
    October 2021
91. GUO Y, Shi S, Zhou X, Liu L, et al
    The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.
    J Nephrol. 2021 Oct 21. pii: 10.1007/s40620-021-01176.
    PubMed     Abstract available
    
    
    
92. VAJGEL G, Correia MRB, Costa CLC, Sette LH, et al
    Nephrology pictures: pemphigus vulgaris and membranous nephropathy.
    J Nephrol. 2021 Oct 15. pii: 10.1007/s40620-021-01151.
    PubMed    
    
    
    
93. GUO W, Tan PH, Baikunje S
    Membranous nephropathy in a patient with COVID-19 infection.
    J Nephrol. 2021 Oct 7. pii: 10.1007/s40620-021-01165.
    PubMed    
    
    
    
94. JARRICK S, Lundberg S, Stephansson O, Symreng A, et al
    Pregnancy outcomes in women with immunoglobulin A nephropathy: a nationwide population-based cohort study.
    J Nephrol. 2021;34:1591-1598.
    PubMed     Abstract available
    
    
    September 2021
95. MASSET C, Renaudin K, Kervella D, Chapelet A, et al
    Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.
    J Nephrol. 2021 Sep 24. pii: 10.1007/s40620-021-01144.
    PubMed    
    
    
    July 2021
96. LUAN R, Tian G, Zhang H, Shi X, et al
    Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
    J Nephrol. 2021 Jul 22. pii: 10.1007/s40620-021-01118.
    PubMed     Abstract available
    
    
    
97. KANT S, Arend LJ, Gapud E, Seo P, et al
    Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis.
    J Nephrol. 2021 Jul 20. pii: 10.1007/s40620-021-01126.
    PubMed     Abstract available
    
    
    June 2021
98. GEETHA D, Attarwala N, Zhang C, Kant S, et al
    Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
    J Nephrol. 2021 Jun 28. pii: 10.1007/s40620-021-01095.
    PubMed     Abstract available
    
    
    
99. BINET Q, Aydin S, Lengele JP, Cambier JF, et al
    Lessons for the clinical nephrologist: an uncommon cause of pulmonary-renal syndrome.
    J Nephrol. 2021;34:935-938.
    PubMed     Abstract available
    
    
    May 2021
100. NAGAI M, Kobayashi N, Izumi N, Ohbayashi T, et al
     Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy.
     J Nephrol. 2021 May 20. pii: 10.1007/s40620-021-01064.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.